Abstract
It is often suggested that there are substantial anatomic barriers to the passage of antibiotics from the circulation into tissues and fluids of the body. In fact, most capillary beds are fenestrated and allow the passage of antimicrobial agents into tissue fluids fairly readily. At equilibrium, the mean concentrations of free (unbound) antibiotic in plasma and tissue fluids over the dosing interval are equal. However, the time to achieve equilibrium may range from minutes to days, depending on the ratio of surface area to volume of the tissue fluid compartment. There are several sites in the body in which nonfenestrated capillary beds pose appreciable barriers to the diffusion of antibiotics, namely the central nervous system, the eye and the prostate gland. Only lipid-soluble drugs traverse these capillaries readily. If the nonporosity of the capillaries were the only barrier to drug diffusion in these sites, the mean concentrations would eventually be equal to those in the plasma. However, in the central nervous system and the retina of the eye, transport pumps for organic anions combine with the effect of nonporous capillaries to produce concentrations which, even at equilibrium, are lower than those in the plasma. Bulk flow may also play a role in lowering drug concentrations in the cerebrospinal fluid. In the prostate gland, pH partition may cause mean concentrations in the prostatic secretions to differ from those in the plasma at equilibrium.
Similar content being viewed by others
References
Gonda I: On predictions of free antibiotic (cefazolin) concentrations in extravascular fluids from ‘logarithmic mean serum concentrations’. Journal of Antimicrobial Chemotherapy 1982, 9: 53–56.
Barza M, Cuchural G: General principles of antibiotic tissue penetration. Journal of Antimicrobial Chemotherapy 1985, 15, Supplement A: 59–75.
Craig WA, Welling PG: Protein binding of antimicrobials: clinical, pharmacokinetic and therapeutic implications. Clinical Pharmacokinetics 1977, 2: 252–268.
Cunha-Vaz J: Sites and functions of the blood-retinal barriers. In: Cunha-Vaz J (ed): The blood-retinal barriers. Plenum Press, New York, 1980, p. 101–117.
Van Etta L, Peterson LR, Fasching CE, Gerding DN: Effect of the ratio of surface area to volume on the penetration of antibiotics into extravascular spaces in an in vitro model. Journal of Infections Diseases 1982, 146: 423–428.
Ryan DM: Influence of surface area/volume ratio on the kinetics of antibiotics in different tissues and tissue fluids. Scandinavian Journal of Infectious Diseases 1985, Supplement 44: 24–33.
Lunke RJ, Fitzgerald RH, Washington JA: Pharmacokinetics of cefamandole in osseous tissue. Antimicrobial Agents and Chemotherapy 1981, 19: 851–858.
Daly RC, Fitzgerald RH, Washington JA: Penetration of cefazolin into normal and osteomyelitic canine cortical bone. Antimicrobial Agents and Chemotherapy 1982, 22: 461–469.
Dorovini-Zis K, Anders JJ, Brightman MW: Cerebral endothelium, blood-brain-barrier and the astrocyte membrane. In: Cunha-Vaz JG (ed): The blood-retinal barriers. Plenum Press, New York, 1980, p. 65–79.
Rall DP: Drug entry into brain and cerebrospinal fluid. In: Brodie BB, Gillette JR (ed): Concepts in biochemical pharmacology. Springer, Berlin, 1971, p. 240–248.
Pardridge WM: Blood-brain barrier interface between internal medicine and the brain. Annals of Internal Medicine 1986, 105: 82–95.
Barza M, Brown RB, Shanks C, Gamble C, Weinstein L: Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline and oxytetracycline in dogs. Antimicrobial Agents and Chemotherapy 1975, 8: 713–720.
Spector R: The transport of gentamicin in the choroid plexus and cerebrospinal fluid. Journal of Pharmacology and Experimental Therapy 1975, 194: 82–88.
Thea D, Barza M: Use of antibacterial agents in infections of the central nervous system. Infectious Disease Clinics of North America 1989, 3: 553–570.
Bito LZ, DeRousseau CJ: Transport functions of the blood-retinal barrier system and the micro-environment of the retina. In: Cunha-Vaz JG (ed): The blood-retinal barriers. Plenum Press, New York, 1980, p. 133–163.
Maurice DM: Drug exchanges between the blood and vitreous. In: Cunha-Vaz JG (ed): The blood-retinal barriers. Plenum Press, New York, 1980, p. 165–178.
Novack GD, Leopold IH: The blood-aqueous and blood-brain barriers to permeability. American Journal of Ophthalmology 1988, 105: 412–416.
Barza M: Antibacterial agents in the treatment of ocular infections. Infectious Disease Clinics of North America 1989, 3: 533–551.
Maurice DM: Injection of drugs into the vitreous body. In: Leopoid IH, Burns RP (ed): Symposium on ocular therapy. Volume 9. John Wiley, New York, 1976, p. 59–72.
Barza M, Kane A, Baum J: Comparison of the effects of continuous and intermittent systemic administration on the penetration of gentamicin into infected rabbit eyes. Journal of Infectious Diseases 1983, 147: 144–148.
Barza M, Cuchural G: The penetration of antibiotics into the prostate in chronic bacterial prostatitis. European Journal of Clinical Microbiology 1984, 3: 503–505.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barza, M. Anatomical barriers for antimicrobial agents. Eur. J. Clin. Microbiol. Infect. Dis. 12 (Suppl 1), S31–S35 (1993). https://doi.org/10.1007/BF02389875
Issue Date:
DOI: https://doi.org/10.1007/BF02389875